Theralink Technologies
Golden
About Theralink Technologies
Theralink Technologies is a molecular company specializing in patented, biomarker assay services that target multiple areas of oncology. Their research indicates that genomic and transcriptomic information alone provides an incomplete information resource for physicians to make patient-specific treatment decisions. The company was founded in 2005 and is headquartered in Baton Rouge, Louisiana.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.2M
- Funding stage: IPO
- Last round: Post-IPO Equity (Nov 2022)
- Ticker: otcpink:OBMP
- Website: theralink.com
- Phone: 888-585-4923
Industries & Categories
Biotechnology, Health Care, Medical, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/theralink-technologies-2240826 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.